Discriminating radiation necrosis from tumor progression in gliomas: A systematic review what is the best imaging modality?

Journal of Neuro-Oncology

Volumn 112, Issue 2, 2013, Pages 141-152

  Shah, Ashish H ^a   Snelling, Brian ^a   Bregy, Amade ^a   Patel, Payal R ^b   Tememe, Danoushka ^a   Bhatia, Rita ^c   Sklar, Evelyn ^c   Komotar, Ricardo J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Nova Southeastern University   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Glioma; Radiation necrosis; Systematic review; Tumor progression

Indexed keywords

FLUORODEOXYGLUCOSE;

BRAIN DAMAGE; CANCER GROWTH; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; GLIOMA; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS; RECURRENT CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; BRAIN TUMOR; DISEASE COURSE; NECROSIS; RADIATION INJURY;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; GLIOMA; HUMANS; NECROSIS; RADIATION INJURIES;

EID: 84883763459     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1059-9     Document Type: Review

References (55)

1. Burger PC, Mahley MS Jr, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44:1256-1272 (Pubitemid 10197395)
2. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217:377-384
3. Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7:243-252 (Pubitemid 11149307)
4. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280 (Pubitemid 20195640)
5. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963-1972. doi: 10.1200/JCO.2009.26.3541
6. Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44:2020-2027 (Pubitemid 24349499)
7. Chuba PJ, Aronin P, Bhambhani K, Eichenhorn M, Zamarano L, Cianci P, Muhlbauer M, Porter AT, Fontanesi J (1997) Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 80:2005-2012 (Pubitemid 27479797)
8. Brandes AA, Tosoni A, Spagnolli F, Frezza G, Leonardi M, Calbucci F, Franceschi E (2008) Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro-oncology 10:361-367. doi: 10.1215/15228517-2008-008
9. Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1-11. doi: 10.1007/s11060-009-9897-1
10. Czernicki T, Szeszkowski W, Marchel A, Golebiowski M (2009) Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis. Folia Neuropathol 47:43-49
11. Hu X, Wong KK, Young GS, Guo L, Wong ST (2011) Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging 33:296-305. doi: 10.1002/jmri.22432
12. Santra A, Sharma P, Kumar R, Bal C, Kumar A, Julka PK, Malhotra A (2011) Comparison of glucoheptonate single photon emission computed tomography and contrast-enhanced MRI in detection of recurrent glioma. Nucl Med Commun 32:206-211. doi: 10.1097/MNM.0b013e328341c3e9
13. Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging. Radiology 253:486-496. doi: 10.1148/radiol.2532090007
14. Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearshen D, Babajani-Feremi A (2011) Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro-oncology 13:1037-1046. doi: 10.1093/neuonc/nor075
15. Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW, Gonzalez RG, Lev MH (2010) Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol 17:282-290. doi: 10.1016/j.acra.2009.10. 024
16. Tie J, Gunawardana DH, Rosenthal MA (2008) Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT. J Clin Neurosci 15:1327-1334. doi: 10.1016/j.jocn.2007.12.008
17. Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH (2010) Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Clin Neurol Neurosurg 112:758-765. doi: 10.1016/j.clineuro.2010.06.005
18. Amin A, Moustafa H, Ahmed E, El-Toukhy M (2012) Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results. J Neurooncol 106:579-587. doi: 10.1007/s11060-011-0694-2
19. Nakajima T, Kumabe T, Kanamori M, Saito R, Tashiro M, Watanabe M, Tominaga T (2009) Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography. Neurol Med Chir 49:394-401
20. Peca C, Pacelli R, Elefante A, Del Basso De Caro ML, Vergara P, Mariniello G, Giamundo A, Maiuri F (2009) Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis? Clin Neurol Neurosurg 111:331-334 doi: 10.1016/j.clineuro.2008.11.003
21. Prat R, Galeano I, Lucas A, Martinez JC, Martin M, Amador R, Reynes G (2010) Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-d-glucose positron emission tomography for detection of recurrence or grade increase in gliomas. J Clin Neurosci 17:50-53. doi: 10.1016/j.jocn.2009.02.035
22. Jain R, Narang J, Schultz L, Scarpace L, Saksena S, Brown S, Rock JP, Rosenblum M, Gutierrez J, Mikkelsen T (2011) Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors? AJNR Am J Neuroradiol 32:658-663. doi: 10.3174/ajnr.A2378
23. Koot RW, Habraken JB, Hulshof MC, Paans AM, Bosch DA, Pruim J (2008) What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy? Acta Neurochir 150:345-349. doi: 10.1007/s00701-007-1494-5
24. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K (2008) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49:694-699. doi: 10.2967/jnumed.107.048082 (Pubitemid 351717532)
25. Xiangsong Z, Weian C (2007) Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET. J Neurooncol 82:305-311. doi: 10.1007/s11060-006-9286-y (Pubitemid 46614394)
26. Yamane T, Sakamoto S, Senda M (2010) Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm. Eur J Nucl Med Mol imaging 37:685-690. doi: 10.1007/s00259-009-1302-y
27. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48. doi: 10.1186/1748-717X-6-48
28. Kim YZ, Kim DY, Yoo H, Yang HS, Shin SH, Hong EK, Cho KH, Lee SH (2007) Radiation-induced necrosis deteriorating neurological symptoms and mimicking progression of brain metastasis after stereotactic-guided radiotherapy. Cancer Res Treat 39:16-21. doi: 10.4143/crt.2007.39.1.16
29. Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH (2005) Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol 26:1967-1972
30. Byrne TN (1994) Imaging of gliomas. Semin Oncol 21:162-171 (Pubitemid 24125956)
31. Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T, Ishikawa H, Hatakeyama R (1993) The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 20:39-45 (Pubitemid 23015335)
32. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shidara N (1993) Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 7:257-263 (Pubitemid 24012437)
33. Yoshii Y, Moritake T, Suzuki K, Fujita K, Nose T, Satou M (1996) Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. AJNR Am J Neuroradiol 17:1773-1776 (Pubitemid 26354789)
34. Yoshii Y, Moritake T, Yamamoto T, Takano S, Tsuboi K, Hyodo A, Nose T, Satou M (1996) Correlation of histopathological factor of brain tumor and high thallium-201 uptake in single photon emission computed tomography. Noshuyo byori 13:61-65
35. Fatterpekar GM, Galheigo D, Narayana A, Johnson G, Knopp E (2012) Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum-use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 198:19-26. doi: 10.2214/AJR.11.7417
36. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859-867 (Pubitemid 44897737)
37. Paulson ES, Schmainda KM (2008) Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 249:601-613. doi: 10.1148/radiol.2492071659
38. Kang Y, Choi SH, Kim YJ, Kim KG, Sohn CH, Kim JH, Yun TJ, Chang KH (2011) Gliomas: histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging - correlation with tumor grade. Radiology 261:882-890. doi: 10.1148/radiol.11110686
39. Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, Kapilamoorthy TR, Nair S (2009) Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol 94:87-96. doi: 10.1007/s11060-009-9807-6
40. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998 (Pubitemid 37444849)
41. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GRt, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 25:214-221 (Pubitemid 38235298)
42. Morita N, Wang S, Chawla S, Poptani H, Melhem ER (2010) Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 32:803-808. doi: 10.1002/jmri.22324
43. Siu A, Wind JJ, Iorgulescu JB, Chan TA, Yamada Y, Sherman JH (2012) Radiation necrosis following treatment of high grade glioma - a review of the literature and current understanding. Acta Neurochir 154:191-201; discussion 201. doi: 10.1007/s00701-011-1228-6
44. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453-461. doi: 10.1016/S1470-2045(08)70125-6 (Pubitemid 351597795)
45. Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH (2007) Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 84:63-69. doi: 10.1007/s11060-007-9341-3 (Pubitemid 47103445)
46. Gomez-Rio M, Rodriguez-Fernandez A, Ramos-Font C, Lopez-Ramirez E, Llamas-Elvira JM (2008) Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence. Eur J Nucl Med Mol imaging 35:966-975. doi: 10.1007/s00259-007-0661-5
47. Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT (1994) Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 163:1459-1465
48. Olivero WC, Dulebohn SC, Lister JR (1995) The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry 58:250-252
49. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19:407-413 (Pubitemid 30422740)
50. Stokkel M, Stevens H, Taphoorn M, Van Rijk P (1999) Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera - a pilot study. Nucl Med Commun 20:411-417 (Pubitemid 29274174)
51. Thompson TP, Lunsford LD, Kondziolka D (1999) Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg 73:9-14 (Pubitemid 30344992)
52. Kong DS, Kim ST, Kim EH, Lim DH, Kim WS, Suh YL, Lee JI, Park K, Kim JH, Nam DH (2011) Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status. AJNR Am J Neuroradiol 32:382-387. doi: 10.3174/ajnr.A2286
53. Kim CK et al (1991) New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 10(1):85-91
54. Bobek-Billewicz B et al (2010) Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 48(2):81-92
55. Bisdas S et al (2011) Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging. Acad Radiol 18(5):575-583